More
and more patients of the antibiotic Levaquin have decided to take legal action
against drugmakers after experiencing serious side effects, which usually
include tendon and rotator cuff damage. The antibiotic, often prescribed for
upper respiratory infections, was approved for the United States market in 1996
and enjoyed relative popularity ever since. When it was approved it included a
warning on its label of the possibility for tendon damages, although these Levaquin side effects were effectively buried in a list of other potential side
effects.
Many of the Levaquin lawsuits are concentrated in New Jersey, where the first of almost two thousand trials is set to begin soon. Federal Levaquin litigation involves more than 1,300 individual cases, which have been consolidated in multidistrict litigations which are set to take place in the United States District Court of Minnesota. Levaquin litigations in most cases is still pending, so patients do not know what kind of settlement to expect, if anything. Depending on how the first cases in consolidated litigations pan out, it is possible that the makers of Levaquin will choose to make out-of-court settlement offerings towards some patients.
Former Levaquin patients who have experienced Levaquin side effects should take legal questions to an experienced personal injury lawyer. Potential plaintiffs should act fast to avoid the statue of limitations and should talk to their doctor to see if their tendon problems could be linked to their use of the drug.
No comments:
Post a Comment